GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PLK1 in complex with a novel 5,6- DIHYDROIMIDAZOLO[1,5-F]PTERIDINE inhibitor.

Analyse Crystal structure of PLK1 in complex with a novel 5,6… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5TA6
Type
protein
Length
294 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase PLK1
EC
2.7.11.21
UniProt
P53350
Ligands
79D, ZN
Pockets
4 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase PLK1 (EC 2.7.11.21)protein29435% helix, 19% strandP53350

Ligands and binding sites

  • 79D · 4-{[(6R)-7-cyano-5-cyclopentyl-6-ethyl-5,6-dihydroimidazo[1,5-f]pteridin-3-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14870.710.814879D
21010.470.8021empty
3940.350.7517empty
4500.310.7612empty

Compared structures

  • 5TA6 · Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.